Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese Subjects

Status:
Completed

Trial end date:
2010-03-01

Target enrollment:

Participant gender:

The purpose of this open-label extension study is to evaluate the safety and efficacy of velneperit (S-2367) in obese subjects.

Phase 2

Shionogi